Diabetes Technology & Therapeutics
Mary Ann Liebert Inc. · United States
Metrics
- Impact factor
- 7.4+1.1 Clarivate JCR
- WoS quartile
- Q1 Clarivate JCR, best category
- SJR
- 2.663Q1 SCImago
- h-index
- 79
- CAS tier
- Tier 1 Chinese Academy of Sciences
- Citations per paper
- 6.68 last 2 years
- Articles per year
- 118
- Self-citation
- 17.5%
- Fee (APC), est.
- $4,039 estimated, check the journal
About this journal
- ISSN
- 1520-9156 (print) · 1557-8593 (online)
- Publisher
- Mary Ann Liebert Inc.
- Country
- United States · Northern America
- Indexed in
- SCIE
- Access
- Hybrid · 23.7% gold OA
- Founded
- 1999
- Frequency
- Monthly
- Original research
- 97.5%
- Subject areas
- Biochemistry, Genetics and Molecular Biology, Health Professions, Medicine
- Categories
- Medicine, Endocrinology & Metabolism
- Common topics
- Medicine, Biology, Endocrinology, Diabetes mellitus, Internal medicine
Similar journals
- Q1WoS
Cell
Impact factor 45.1h-index 705SJR 24.59 - Q1WoS
Journal of the American Chemical Society
Impact factor 16.6h-index 542SJR 5.49 - Q1WoS
Nature Genetics
Impact factor 25.5h-index 527SJR 15.38 - Q1WoS
Nature Medicine
Impact factor 52.5h-index 497SJR 17.50 - Q1WoS
Journal of Clinical Oncology
Impact factor 44.7h-index 494SJR 4.65 - Q1WoS
Nucleic Acids Research
Impact factor 15h-index 452SJR 8.11
Figures as of the last import; ranks are a guide, not a verdict. Back to all journals